BIOREM INC (BRM.CA) Stock Fundamental Analysis
Canada - TSX Venture Exchange - TSX-V:BRM - CA09068G1046 - Common Stock
2.55 CAD
+0.03 (+1.19%)
We assign a fundamental rating of 7 out of 10 to BRM. BRM was compared to 24 industry peers in the Commercial Services & Supplies industry. Both the health and profitability get an excellent rating, making BRM a very profitable company, without any liquidiy or solvency issues. BRM is not valued too expensively and it also shows a decent growth rate. With these ratings, BRM could be worth investigating further for quality investing!.
1. Profitability
1.1 Basic Checks
In the past year BRM was profitable.
In the past year BRM had a positive cash flow from operations.
Each year in the past 5 years BRM has been profitable.
In the past 5 years BRM always reported a positive cash flow from operatings.
1.2 Ratios
BRM has a better Return On Assets (7.60%) than 91.67% of its industry peers.
The Return On Equity of BRM (17.30%) is better than 87.50% of its industry peers.
With an excellent Return On Invested Capital value of 15.98%, BRM belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for BRM is significantly above the industry average of 5.81%.
The 3 year average ROIC (25.13%) for BRM is well above the current ROIC(15.98%). The reason for the recent decline needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.6% | ||
| ROE | 17.3% | ||
| ROIC | 15.98% |
ROA(3y)9.17%
ROA(5y)8.76%
ROE(3y)32.25%
ROE(5y)35.65%
ROIC(3y)25.13%
ROIC(5y)23.46%
1.3 Margins
With a decent Profit Margin value of 6.08%, BRM is doing good in the industry, outperforming 75.00% of the companies in the same industry.
BRM's Profit Margin has improved in the last couple of years.
The Operating Margin of BRM (8.87%) is better than 79.17% of its industry peers.
In the last couple of years the Operating Margin of BRM has grown nicely.
BRM has a Gross Margin (24.25%) which is comparable to the rest of the industry.
In the last couple of years the Gross Margin of BRM has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 8.87% | ||
| PM (TTM) | 6.08% | ||
| GM | 24.25% |
OM growth 3Y7.19%
OM growth 5YN/A
PM growth 3Y15.35%
PM growth 5YN/A
GM growth 3Y1.79%
GM growth 5Y2.67%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so BRM is creating value.
Compared to 1 year ago, BRM has more shares outstanding
The number of shares outstanding for BRM has been reduced compared to 5 years ago.
The debt/assets ratio for BRM has been reduced compared to a year ago.
2.2 Solvency
An Altman-Z score of 3.83 indicates that BRM is not in any danger for bankruptcy at the moment.
The Altman-Z score of BRM (3.83) is better than 91.67% of its industry peers.
The Debt to FCF ratio of BRM is 1.39, which is an excellent value as it means it would take BRM, only 1.39 years of fcf income to pay off all of its debts.
BRM's Debt to FCF ratio of 1.39 is amongst the best of the industry. BRM outperforms 95.83% of its industry peers.
A Debt/Equity ratio of 0.20 indicates that BRM is not too dependend on debt financing.
BRM has a Debt to Equity ratio of 0.20. This is amongst the best in the industry. BRM outperforms 87.50% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.2 | ||
| Debt/FCF | 1.39 | ||
| Altman-Z | 3.83 |
ROIC/WACC2.14
WACC7.47%
2.3 Liquidity
A Current Ratio of 1.89 indicates that BRM should not have too much problems paying its short term obligations.
BRM has a Current ratio of 1.89. This is amongst the best in the industry. BRM outperforms 87.50% of its industry peers.
A Quick Ratio of 1.73 indicates that BRM should not have too much problems paying its short term obligations.
With an excellent Quick ratio value of 1.73, BRM belongs to the best of the industry, outperforming 83.33% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.89 | ||
| Quick Ratio | 1.73 |
3. Growth
3.1 Past
The earnings per share for BRM have decreased strongly by -64.28% in the last year.
Measured over the past years, BRM shows a very strong growth in Earnings Per Share. The EPS has been growing by 32.08% on average per year.
Looking at the last year, BRM shows a very negative growth in Revenue. The Revenue has decreased by -24.88% in the last year.
Measured over the past years, BRM shows a quite strong growth in Revenue. The Revenue has been growing by 12.63% on average per year.
EPS 1Y (TTM)-64.28%
EPS 3Y32.08%
EPS 5YN/A
EPS Q2Q%-47.19%
Revenue 1Y (TTM)-24.88%
Revenue growth 3Y15.2%
Revenue growth 5Y12.63%
Sales Q2Q%-24.4%
3.2 Future
BRM is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 21.40% yearly.
BRM is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 10.68% yearly.
EPS Next Y5.26%
EPS Next 2Y21.4%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year5.42%
Revenue Next 2Y10.68%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 23.18, which indicates a rather expensive current valuation of BRM.
Based on the Price/Earnings ratio, BRM is valued a bit cheaper than 79.17% of the companies in the same industry.
BRM's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.00.
Based on the Price/Forward Earnings ratio of 8.84, the valuation of BRM can be described as reasonable.
Compared to the rest of the industry, the Price/Forward Earnings ratio of BRM indicates a rather cheap valuation: BRM is cheaper than 100.00% of the companies listed in the same industry.
BRM's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 23.70.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 23.18 | ||
| Fwd PE | 8.84 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BRM indicates a somewhat cheap valuation: BRM is cheaper than 75.00% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of BRM indicates a somewhat cheap valuation: BRM is cheaper than 75.00% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 18.41 | ||
| EV/EBITDA | 9.8 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates BRM does not grow enough to justify the current Price/Earnings ratio.
The excellent profitability rating of BRM may justify a higher PE ratio.
BRM's earnings are expected to grow with 21.40% in the coming years. This may justify a more expensive valuation.
PEG (NY)4.4
PEG (5Y)N/A
EPS Next 2Y21.4%
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for BRM!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
TSX-V:BRM (1/8/2026, 7:00:00 PM)
2.55
+0.03 (+1.19%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners0.16%
Inst Owner ChangeN/A
Ins Owners2%
Ins Owner ChangeN/A
Market Cap40.98M
Revenue(TTM)34.73M
Net Income(TTM)2.11M
Analysts84.44
Price Target3.57 (40%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)11.11%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)4.29%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 23.18 | ||
| Fwd PE | 8.84 | ||
| P/S | 1.18 | ||
| P/FCF | 18.41 | ||
| P/OCF | 15.94 | ||
| P/B | 3.36 | ||
| P/tB | 3.36 | ||
| EV/EBITDA | 9.8 |
EPS(TTM)0.11
EY4.31%
EPS(NY)0.29
Fwd EY11.31%
FCF(TTM)0.14
FCFY5.43%
OCF(TTM)0.16
OCFY6.27%
SpS2.16
BVpS0.76
TBVpS0.76
PEG (NY)4.4
PEG (5Y)N/A
Graham Number1.37
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.6% | ||
| ROE | 17.3% | ||
| ROCE | 21.09% | ||
| ROIC | 15.98% | ||
| ROICexc | 37.31% | ||
| ROICexgc | 37.31% | ||
| OM | 8.87% | ||
| PM (TTM) | 6.08% | ||
| GM | 24.25% | ||
| FCFM | 6.41% |
ROA(3y)9.17%
ROA(5y)8.76%
ROE(3y)32.25%
ROE(5y)35.65%
ROIC(3y)25.13%
ROIC(5y)23.46%
ROICexc(3y)41.23%
ROICexc(5y)N/A
ROICexgc(3y)41.23%
ROICexgc(5y)N/A
ROCE(3y)33.17%
ROCE(5y)30.97%
ROICexgc growth 3Y-30.69%
ROICexgc growth 5YN/A
ROICexc growth 3Y-30.69%
ROICexc growth 5YN/A
OM growth 3Y7.19%
OM growth 5YN/A
PM growth 3Y15.35%
PM growth 5YN/A
GM growth 3Y1.79%
GM growth 5Y2.67%
F-Score4
Asset Turnover1.25
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.2 | ||
| Debt/FCF | 1.39 | ||
| Debt/EBITDA | 0.67 | ||
| Cap/Depr | 66.81% | ||
| Cap/Sales | 0.99% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 71.47% | ||
| Profit Quality | 105.47% | ||
| Current Ratio | 1.89 | ||
| Quick Ratio | 1.73 | ||
| Altman-Z | 3.83 |
F-Score4
WACC7.47%
ROIC/WACC2.14
Cap/Depr(3y)93.69%
Cap/Depr(5y)79.96%
Cap/Sales(3y)1.3%
Cap/Sales(5y)1.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-64.28%
EPS 3Y32.08%
EPS 5YN/A
EPS Q2Q%-47.19%
EPS Next Y5.26%
EPS Next 2Y21.4%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-24.88%
Revenue growth 3Y15.2%
Revenue growth 5Y12.63%
Sales Q2Q%-24.4%
Revenue Next Year5.42%
Revenue Next 2Y10.68%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-59.97%
EBIT growth 3Y23.48%
EBIT growth 5YN/A
EBIT Next Year33.62%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-8.22%
FCF growth 3Y-3.66%
FCF growth 5Y6.73%
OCF growth 1Y-18.62%
OCF growth 3Y-0.86%
OCF growth 5Y7.83%
BIOREM INC / BRM.CA FAQ
What is the fundamental rating for BRM stock?
ChartMill assigns a fundamental rating of 7 / 10 to BRM.CA.
What is the valuation status of BIOREM INC (BRM.CA) stock?
ChartMill assigns a valuation rating of 6 / 10 to BIOREM INC (BRM.CA). This can be considered as Fairly Valued.
How profitable is BIOREM INC (BRM.CA) stock?
BIOREM INC (BRM.CA) has a profitability rating of 9 / 10.
What is the expected EPS growth for BIOREM INC (BRM.CA) stock?
The Earnings per Share (EPS) of BIOREM INC (BRM.CA) is expected to grow by 5.26% in the next year.